medline.ch Onkologie Haut

	Melanoma of unknown primary presenting as intestinal obstruction: a diagnostic challenge. Rom J Morphol Embryol Palc, Andronic O, Bolocan A, Dinulescu A, P, Ion D, P. PMID: 41787628 [PubMed - in process]
	Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study. J Immunother Cancer Gaughan EM, Kim M, Mendez I, Rao AD, Wei M, So A, Zhong X, Berking C, Jiang R, Kim TM, Dalle S, Robert C, Danson S, Alam S, Charles J, Davies T, Debus D, Dzienis M, Frazer R, Gebhardt C, Geidel G, Hassel JC, Hansen I, Heppt MV, Hildebrandt L, Isaacs JM, Suh KJ, Keam B, Kim YJ, Lesimple T, Saiag P, Delibes A, Barnett R, Krepler C, Gandhi K, Qizilbash N, Shui IM, Tan XL, Sullivan RJ. PMID: 41786455 [PubMed - in process]
	Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol van den Hoek L, Burgmans M, Tong T, Goeman J, Speetjens F, Zunder S, van Erkel A, van der Meer R, van Rijswijk C, Lutjeboer J, Koolhaas D, Jonker-Bos M, Roozen I, Kropff S, van Meerten EVP, Zoethout R, Sitsen E, Helmerhorst H, Tijl F, Blank C, Kapiteijn E. PMID: 41785896 [PubMed - in process]
	Pleural Metastases From Acral Lentiginous Melanoma Diagnosed by Medical Thoracoscopy. Respirol Case Rep Chong AR, Ng KL, Huan NC, Mohd Aminudin NH, Hassan F, Mohamed Nordin K. PMID: 41783719 [PubMed]
	Efficacy and Safety of DNV3 (a Lymphocyte-activation Gene 3-blocking Antibody) Combined With Toripalimab and Chemotherapy in Advanced Melanoma: An Open-label, Single-arm Clinical Trial. MedComm (2020) Lin J, Chen L, Chen L, Wang D, Lu Y, Zhang H, Chen P, Yan W, Xiao Z, Chen Y. PMID: 41782961 [PubMed]
	Cutaneous Epithelioid/Pleomorphic Rhabdomyosarcoma, Melanoma in Disguise? An Immunohistochemical, Molecular and Epigenetic Study of 13 Patients. Mod Pathol Ulici V, Ameline B, John I, Dermawan JK, Karunamurthy A, Dehner CA, Fernandez AP, Azzato E, Hattery T, Kilpatrick SE, Isaacson AL, Ko JS, Fritchie KJ, Baumhoer D, Billings SD. PMID: 41780801 [PubMed - as supplied by publisher]
	Integrated analysis identifies CCNA2 as a candidate diagnostic and prognostic biomarker in oral tongue squamous cell carcinoma. J Appl Oral Sci Gumedag C, Atay S. PMID: 41779475 [PubMed - indexed for MEDLINE]
	Comparison of [18F]PFPN and [18F]FDG PET in mucosal melanoma: diagnostic performance, staging impact, and correlation with molecular markers. Clin Cancer Res Lin Z, Tang C, Liu T, Wang X, Wu Z, Hu F, Gai Y, Ruan W, Zhang X, Lan X. PMID: 41779012 [PubMed - as supplied by publisher]
	Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC). J Immunother Cancer Ninmer EK, Petroni GR, Gastman BR, Gaughan EM, Isaacs JM, Haden K, Kaur V, Wages NA, Chianese-Bullock KA, Smith KT, Wright P, Bryant J, Dunlap-Brown M, Engel JA, Bekiranov S, Mauldin IS, Truong TG, Bullock TNJ, Slingluff CL Jr. PMID: 41775435 [PubMed - in process]
	Occupational Sun Exposure and Melanoma Development: A Review of the Evidence. Australas J Dermatol Whiteman DC, Williams GJ, Thompson JF. PMID: 41772818 [PubMed - as supplied by publisher]
	Revealing the Physician's Task Conceptualization in Melanoma Treatment: Qualitative User Experience Study. JMIR Cancer Hartmann EM, Küper A, Swoboda J, Beckmann CL, Lodde GC, Livingstone E, Schadendorf D, Sachweh S. PMID: 41770590 [PubMed - in process]
	Metabolic crosstalk between oral microbiota and the host in OSCC: emerging roles of microbial metabolites in tumor initiation and progression. Front Cell Infect Microbiol Wu Y, Han B, Zhang B, Li J, Ren B, Su Z. PMID: 41769336 [PubMed - indexed for MEDLINE]
	A phase 2 study of abemaciclib in patients with brain metastases secondary to non-small cell lung cancer or melanoma. Neurooncol Adv Sahebjam S, Bazer DA, Rhun EL, Queirolo P, Jerusalem G, Johnston EL, Conte P. PMID: 41768125 [PubMed]
	Tumor immune-vascular crosstalk: synergy and translation of immune checkpoint inhibitors and anti-angiogenic agents in melanoma. Front Immunol Xie Y, Ho I, Liu Z, Chen K, Zhou M, Ha G, Duan L, Zhao Z, Cai D. PMID: 41766910 [PubMed - in process]
	Construction and validation of a novel diagnostic model for esophageal squamous cell carcinoma: an integrated analysis of multi-omics data. Front Immunol Cui Y, Li S, Wu Z, Jin Y, Yu J, Chen Y, Chen J, Chang J, Yan Y, Li X, Li N, Hu S, Zhu C, Feng L. PMID: 41766902 [PubMed - indexed for MEDLINE]
	Ultrasonographic and histopathological correlation in choroidal melanoma: survival outcomes from a single-center study in Serbia. Melanoma Res Vasovi, Ra, Da, Kalezi, Kuzmanovi, Simonovi, Vasilijevi, Kova, Petrovi, Marjanovi. PMID: 41766297 [PubMed - as supplied by publisher]
	Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. Melanoma Res Yang K, Wu D. PMID: 41766295 [PubMed - as supplied by publisher]
	Comment On "Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node-Positive Melanoma: Feasibility, Safety, and Early Outcomes". J Surg Oncol Zhang Y, Li C, Shan L. PMID: 41766105 [PubMed - as supplied by publisher]
	Pharmaceutical insights into nanoscale drug delivery systems and chromatographic approaches for melanoma treatment. J Pharm Biomed Anal Deljavan Ghodrati A, Gebrehiwot W, Amasya G, Gumustas M, Sengel-Turk CT. PMID: 41762483 [PubMed - as supplied by publisher]
	PROTAC-based protein degradation: a window of opportunity for melanoma therapy. J Biomed Sci Gentile G, D'Aguanno S, Di Martile M, Petricca A, Valentini E, Scalera S, Del Bufalo D. PMID: 41761284 [PubMed - in process]

Artikel 1 - 20 / 141635

Seite 1 von 7082

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung